Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease

Current Breast Cancer Reports - United States
doi 10.1007/s12609-009-0021-5
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Statins May Reduce Risk of Depression

BMJ
2003English

Migraine and Possible Etiologic Heterogeneity for Hormone-Receptor-Negative Breast Cancer

Scientific Reports
Multidisciplinary
2015English

Treatment of Advanced Hormone Receptor-Positive (HR+) HER2-negative Breast Cancer

Geburtshilfe und Frauenheilkunde
GynecologyMidwiferyMaternityObstetrics
2019English

Reproductive Risk Factors and Oestrogen/Progesterone Receptor-Negative Breast Cancer in the Breast Cancer Family Registry

British Journal of Cancer
Cancer ResearchOncology
2014English

A Multigene Predictor of Metastatic Outcome in Early Stage Hormone Receptor-Negative and Triple-Negative Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2010English

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Androgen Receptor-Positive, Triple-Negative Breast Cancer

Cancer
Cancer ResearchOncology
2017English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy